Low aqueous solubility resulting in poor oral bioavailability of drug candidates is an increasingly
common challenge for the pharmaceutical industry. An estimated 60% to 70% of compounds in
early development have poor bioavailability due to low solubility, representing a significant loss in
economic and therapeutic opportunity. Capsugel Dosage Form Solutions has developed a patented
delivery platform based on spray-dried dispersions (SDDs), which is available for license.